Chantal M Ferguson, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
RNA, Small Interfering | 9 | 2024 | 3442 | 0.960 |
Why?
|
Central Nervous System | 2 | 2024 | 1334 | 0.660 |
Why?
|
Lymphedema | 4 | 2016 | 524 | 0.560 |
Why?
|
RNA Interference | 1 | 2024 | 2846 | 0.500 |
Why?
|
Cellulitis | 1 | 2015 | 207 | 0.450 |
Why?
|
Apolipoproteins E | 2 | 2024 | 1437 | 0.310 |
Why?
|
Acetylgalactosamine | 1 | 2024 | 38 | 0.240 |
Why?
|
Huntington Disease | 2 | 2023 | 1141 | 0.230 |
Why?
|
Trinucleotide Repeat Expansion | 2 | 2023 | 247 | 0.230 |
Why?
|
Oligonucleotides, Antisense | 2 | 2024 | 459 | 0.220 |
Why?
|
Amyloidogenic Proteins | 1 | 2024 | 151 | 0.220 |
Why?
|
Gene Silencing | 3 | 2024 | 1512 | 0.210 |
Why?
|
Alzheimer Disease | 1 | 2024 | 8561 | 0.200 |
Why?
|
Drug Administration Routes | 1 | 2021 | 150 | 0.200 |
Why?
|
Apolipoprotein E4 | 1 | 2024 | 709 | 0.170 |
Why?
|
Sheep | 1 | 2021 | 1441 | 0.160 |
Why?
|
Amyloid | 1 | 2024 | 842 | 0.160 |
Why?
|
Breast Neoplasms | 4 | 2016 | 21029 | 0.130 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2024 | 3583 | 0.130 |
Why?
|
Reperfusion Injury | 1 | 2022 | 1023 | 0.130 |
Why?
|
Phlebotomy | 1 | 2015 | 137 | 0.120 |
Why?
|
Arm Injuries | 1 | 2015 | 156 | 0.120 |
Why?
|
Tissue and Organ Procurement | 1 | 2022 | 944 | 0.110 |
Why?
|
Muscle Development | 1 | 2015 | 259 | 0.110 |
Why?
|
Mice | 7 | 2024 | 81209 | 0.110 |
Why?
|
Breast Implantation | 1 | 2016 | 223 | 0.110 |
Why?
|
Mastectomy | 3 | 2016 | 1832 | 0.110 |
Why?
|
Animals | 10 | 2024 | 167960 | 0.110 |
Why?
|
Injections | 1 | 2015 | 830 | 0.100 |
Why?
|
T-Box Domain Proteins | 1 | 2015 | 468 | 0.100 |
Why?
|
Arm | 1 | 2015 | 583 | 0.100 |
Why?
|
Blood Pressure Determination | 1 | 2015 | 640 | 0.100 |
Why?
|
Mice, Transgenic | 1 | 2024 | 9530 | 0.090 |
Why?
|
Liver | 2 | 2024 | 7510 | 0.090 |
Why?
|
Amyloid beta-Peptides | 1 | 2024 | 3841 | 0.090 |
Why?
|
Liver Transplantation | 1 | 2022 | 2325 | 0.090 |
Why?
|
Glioblastoma | 1 | 2024 | 3482 | 0.080 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 1137 | 0.080 |
Why?
|
Zebrafish Proteins | 1 | 2015 | 1006 | 0.080 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2016 | 936 | 0.080 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2016 | 1096 | 0.080 |
Why?
|
MicroRNAs | 1 | 2024 | 3787 | 0.080 |
Why?
|
RNA, Messenger | 2 | 2019 | 12762 | 0.070 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22020 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2015 | 3604 | 0.060 |
Why?
|
Zebrafish | 1 | 2015 | 2997 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2024 | 8985 | 0.050 |
Why?
|
Neostriatum | 1 | 2023 | 246 | 0.050 |
Why?
|
RNA, Double-Stranded | 1 | 2023 | 295 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11902 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5795 | 0.040 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 4924 | 0.040 |
Why?
|
Oligonucleotides | 1 | 2023 | 588 | 0.040 |
Why?
|
Neurons | 1 | 2018 | 9424 | 0.040 |
Why?
|
Organ Preservation | 1 | 2022 | 379 | 0.040 |
Why?
|
Aged, 80 and over | 4 | 2016 | 58980 | 0.040 |
Why?
|
Mice, Nude | 1 | 2024 | 3607 | 0.040 |
Why?
|
Perfusion | 1 | 2022 | 1376 | 0.040 |
Why?
|
Brain | 1 | 2024 | 26951 | 0.040 |
Why?
|
Prospective Studies | 3 | 2016 | 54306 | 0.030 |
Why?
|
Corpus Striatum | 1 | 2023 | 1233 | 0.030 |
Why?
|
Somites | 1 | 2015 | 60 | 0.030 |
Why?
|
Humans | 9 | 2024 | 760613 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11713 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15679 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2018 | 2505 | 0.030 |
Why?
|
HeLa Cells | 1 | 2018 | 3105 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2015 | 858 | 0.030 |
Why?
|
Risk Factors | 2 | 2016 | 74333 | 0.020 |
Why?
|
Taxoids | 1 | 2015 | 669 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2015 | 1900 | 0.020 |
Why?
|
Aged | 4 | 2016 | 169143 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2023 | 3061 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1617 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2015 | 1553 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2018 | 2907 | 0.020 |
Why?
|
Middle Aged | 4 | 2016 | 220359 | 0.020 |
Why?
|
Adult | 4 | 2016 | 220007 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4571 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 16932 | 0.020 |
Why?
|
Incidence | 2 | 2016 | 21391 | 0.020 |
Why?
|
Female | 5 | 2018 | 391246 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3530 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2015 | 1741 | 0.020 |
Why?
|
Male | 1 | 2024 | 359718 | 0.020 |
Why?
|
Rats | 1 | 2022 | 23709 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2015 | 2417 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6544 | 0.020 |
Why?
|
Motor Activity | 1 | 2015 | 2688 | 0.020 |
Why?
|
Lung | 1 | 2023 | 9994 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2016 | 39262 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4716 | 0.010 |
Why?
|
Base Sequence | 1 | 2015 | 12444 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 18955 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12159 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 17624 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11070 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12531 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9185 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 29957 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40139 | 0.010 |
Why?
|
Quality of Life | 1 | 2015 | 13308 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 64981 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 58748 | 0.000 |
Why?
|